Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
QuintilesIMS
McKesson
Citi
Colorcon
Healthtrust
Cipla
Queensland Health
Accenture

Generated: August 23, 2017

DrugPatentWatch Database Preview

SECOBARBITAL SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Secobarbital Sodium, and when can generic versions of Secobarbital Sodium launch?

Secobarbital Sodium is a drug marketed by Lannett, Anabolic, Barr, West Ward, Perrigo, Parke Davis, Wyeth Ayerst, Purepac Pharm, Ivax Pharms, Vitarine, Halsey, Valeant Pharm Intl, Elkins Sinn, Kv Pharm, Watson Labs, Everylife, and Whiteworth Town Plsn. and is included in twenty NDAs.

The generic ingredient in SECOBARBITAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the secobarbital sodium profile page.

Summary for Tradename: SECOBARBITAL SODIUM

Patents:0
Applicants:17
NDAs:20
Bulk Api Vendors: see list22
Clinical Trials: see list2,373
Patent Applications: see list2,086
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SECOBARBITAL SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
SECOBARBITAL SODIUM
secobarbital sodium
CAPSULE;ORAL085903-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Everylife
SECOBARBITAL SODIUM
secobarbital sodium
CAPSULE;ORAL085895-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
SECOBARBITAL SODIUM
secobarbital sodium
CAPSULE;ORAL084762-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
SECOBARBITAL SODIUM
secobarbital sodium
CAPSULE;ORAL084225-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Halsey
SECOBARBITAL SODIUM
secobarbital sodium
CAPSULE;ORAL084676-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
US Department of Justice
Mallinckrodt
Covington
AstraZeneca
Healthtrust
Daiichi Sankyo
Express Scripts
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot